HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > Orbis Marketing

Print e mail rss del Y! myWeb Tweet
 

Help with Mesothelioma

New Web site contains helpful articles for those facing mesothelioma, including information on emerging treatments for mesothelioma.

(EMAILWIRE.COM, July 14, 2004 ) Woodland Hills, CA -- Because mesothelioma is a newly publicized disease, many doctors may have a hard time diagnosing and treating it. Depending on the stage of the disease, the most common treatments are surgical removal of the affected tissues, chemotherapy, or radiation. There is some concern that research into mesothelioma will be minimal, because it is projected to be a short-lived disease in terms of new cases after the next 30 years. However, new research is consistently providing physicians with alternate forms of therapy, and there are many intense studies into control and cure of the disease, so those diagnosed with mesothelioma do have many options and a lot of hope.

Photodynamic therapy is a new approach to treating mesothelioma cancer and is based on using light to kill the cancer cells. In photodynamic therapy, a drug is first administered intravenously that targets and renders the cancerous cells more sensitive in a number of days. The drug is easily eliminated by normal cells, ensuring that they will not be harmed when light therapy is given. After the cells have been given the proper time of exposure to the drug, a special frequency of light laser beams are directed towards the mesothelioma cancer with the intent to eradicate it from the body without having to use more invasive methods. Although there are occasional cases of eye sensitivity and nausea and/or vomiting, the main side effect of photodynamic therapy is skin sensitivity after the procedure is completed.

More information on photodynamic therapy can be found on new Web site, Mesothelioma Help ( http://www.mesohelp.net ) The Web site contains several informative articles, including a primer on emerging treatments for mesothelioma.

The Web site was a joint product of Orbis Marketing and Jimandi Corp. Said editor Jimmy Atkinson, “We wanted to make a site that can actually help those coping with mesothelioma, rather than just another ‘A-OK #1 Spam’ site. This is a hard thing to face, and it’s sad to see ambulance-chasers dominating this field. We aim to change that with Mesothelioma Help.”

Orbis Marketing is a privately held company based in Los Angeles, California. For more information, please visit http://www.orbismarketing.com . Visit Jimandi Corp at http://www.dotmarketer.com . Visit Mesothelioma Help at http://www.mesohelp.net .

###

Contact:
Orbis Marketing
Jim Atkinson
(818) 716-2739
jima@orbismarketing.com
http://www.orbismarketing.com

Contact Information:
Orbis Marketing
Jim Atkinson
Tel:
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:

New Web site contains helpful articles for those facing mesothelioma, including information on emerging treatments for mesothelioma.

Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Satellite TV for PC

Watch Streaming Tv Right on Your PC

Satellitetelevisionforpc.com



 



Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012